Informations sur le produit
- 4-[3-[4-(2-Chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-oxopropyl]morpholine
- WEB 2086BS
- WEB 2086
- 1-Propanone, 3-[4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-(4-morpholinyl)-
- 105219-56-5
- 3-[4-(2-Chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-(4-morpholinyl)-1-propanone
- 3-[4-(2-Chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-(morpholin-4-yl)propan-1-one
- 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, morpholine deriv.
- Morpholine, 4-[3-[4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-oxopropyl]-
- Web 2086
- Voir d'autres synonymes
- Web 2086Bs
Applications Platelet activating factor (PAF) antagonist.
References Casals-Stenzel, J., et al.: J. Pharmacol. Exp. Ther., 241, 974 (1987), Adamus, W.S., et al.: Clin. Pharmacol. Ther., 47, 456 (1990), Brecht, H.M., et al.: Arzneim.-Forsch., 41, 51 (1991),